血浆和肽素、N末端脑钠肽前体和肾上腺髓质素前体N端20肽与慢性心力.doc

血浆和肽素、N末端脑钠肽前体和肾上腺髓质素前体N端20肽与慢性心力.doc

  1. 1、本文档共8页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
血浆和肽素、N末端脑钠肽前体和肾上腺髓质素前体N端20肽与慢性心力.doc

血浆和肽素、N末端脑钠肽前体和肾上腺髓质素前体N端20肽与慢性心力衰竭的关系研究*该项目受重庆市卫生局资助(2011-2-547); *该项目受重庆市卫生局资助(2011-2-547); 何艺1?通讯作者,何艺,女,重庆市黔江中心医院,副主任医师,Email:heyi0721@163.com、冉华1、王正中1、张艳芳1、王丽1、郑全1、梁泊平1 ?通讯作者,何艺,女,重庆市黔江中心医院,副主任医师,Email:heyi0721@163.com (1:重庆市黔江中心医院心内科,重庆409000) (2:重庆医科大学附属第二医院,重庆400016) [摘要] 目的:探讨血浆和肽素(copeptin)、肾上腺髓质素前体N端20肽(PAMP)、N末端脑钠肽前体(NT-proBNP)水平和慢性心力衰竭(CHF)及其严重程度的相关关系。 方法:分别入选CHF患者72例和32例非CHF对照,检测纳入对象血浆copeptin、PAMP和NT-proBNP水平,心脏彩超评价心脏的结构和功能。 结果:CHF患者血浆copeptin、NT-proBNP水平与对照组相比明显升高(p0.001),并随NYHA分级的增加而升高。Copeptin分别与左室舒张末期内径(LVEDD)值、血肌酐、NYHA分级、NT-proBNP呈显著正相关(p0.01),与左室射血分数(LVEF)呈负相关(p0.01)。CHF患者血浆PAMP水平对照组相比无显著差异。 结论:血浆copeptin、NT-proBNP水平在CHF中显著升高,并与CHF的严重程度密切相关。 关键词:慢性心力衰竭;和肽素;肾上腺髓质素前体N端20肽;N末端脑钠肽前体 [中图分类号]:R541.7 [文献标志码]:A The relationship between plasma copeptin, ProAdrenoMedullin N-terminal 20 Peptide, N-terminal pro-brain natriuretic peptidelevels and chronic heart failure He Yi1, Ran Hua1, Wang Zhengzhong1, Zhang Yanfang1, Wang Li1, ZhengQuan1, Liang bopping1, Pu Yi1, Yin Yuehui2 (1: Department of Cardiology,Qianjiang Central Hospital, Chongqing, 409000) (2: Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400016) ABSTRACT Objective: To investigate the relationship between plasma copeptin, ProAdrenoMedullin N-terminal 20 Peptide (PAMP), N-terminal pro-brain natriuretic peptide (NT-proBNP) levels and the severity of chronic heart failure (CHF). Methods: Seventy-two patients with CHF and 32 non-CHF controls were enrolled. Plasma copeptin, PAMP concentrations were measured byenzyme-linked immuno sorbent assay, and the concentration of NT-proBNP was detected by Triaged detection instrument. Results: Plasma copeptin and NT-proBNP levels in patients with CHF were significantly higher than that in non-CHF controls(p0.001), and which were elevated with the increase of the New York Heart Association (NYHA) Class. The concentration of copeptinhad a parallel with left ventricular end-diastolic diamet

文档评论(0)

sunyangbill + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档